Related Experiment Video
Updated: Aug 30, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Atazanavir-Loaded Crosslinked Gamma-Cyclodextrin Nanoparticles to Improve Solubility and Dissolution Characteristics
Darshana Dhabliya1, Shagufta Abdul Qaiyum Khan1, Minal Umate1
1Institute of Pharmaceutical Education and Research, Maharashtra, India.
Atazanavir sulfate nanoparticles (ASNPs) were developed to improve solubility and reduce side effects. The study demonstrated a significant increase in solubility and sustained drug release over 12 hours.
Area of Science:
- Pharmaceutical Nanotechnology
- Drug Delivery Systems
- Antiretroviral Therapy
Background:
- Atazanavir sulfate (AS) exhibits poor aqueous solubility and dissolution-limited bioavailability.
- Immediate-release formulations of AS are associated with significant gastrointestinal, cardiovascular, and organ-specific toxicities.
- Developing novel drug delivery systems is crucial for enhancing AS efficacy and patient safety.
Purpose of the Study:
- To develop atazanavir sulfate-loaded nanoparticles (ASNPs) to improve aqueous solubility and oral bioavailability.
- To engineer ASNPs for sustained drug release over 12 hours, aiming to mitigate AS-associated side effects.
- To characterize the physicochemical properties and drug release profile of the developed ASNPs.
Main Methods:
- ASNPs were prepared using gamma-cyclodextrin (γ-CD) and dimethyl carbonate as a crosslinker.
- Nanoparticle characterization included differential scanning calorimetry (DSC), X-ray diffraction (XRD), entrapment efficiency (EE), particle size, zeta potential, and morphology analysis.
- In vitro drug release studies were conducted in water, acid buffer, and phosphate buffer over a 12-hour period.
Main Results:
- Characterization confirmed the transformation of crystalline AS to an amorphous state within the nanoparticles.
- A significant 11.717-fold increase in AS aqueous solubility was achieved with the nanoparticle formulation.
- The optimal AS:γ-CD (1:1) formulation exhibited high entrapment efficiency and sustained drug release (86-91%) over 12 hours across different media.
Conclusions:
- The developed ASNPs effectively enhance the aqueous solubility of atazanavir sulfate.
- The amorphous state of AS within nanoparticles is responsible for the observed solubility enhancement.
- ASNPs demonstrate potential for sustained drug delivery, which may lead to reduced toxicity and improved therapeutic outcomes for atazanavir sulfate.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Influencing Drug Absorption: Drug Dissolution
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...

